Scientific Poster Presentation Session One

Saturday, April 25, 2009: 12:30 PM-2:00 PM
Session Organizer:
Emma Webb, ACCP
Papers:
194
Evaluation of nonprescription medication use in heart failure patients
Jill H. Cwik, Pharm.D., UMass Memorial Medical Center; Stephanie C. Lemon, Ph.D, UMass Memorial Medical Center; Maichi T. Tran, Pharm.D., BCPS, UMass Memorial Medical Center; Jennifer L. Donovan, PharmD, Massachusetts College of Pharmacy and Health Sciences; Theo E. Meyer, MD, DPhil, UMass Memorial Medical Center
195
Incidence of methadone induced QT-interval prolongation in patients with cardiovascular disease
Wesley R. Zemrak, Pharm.D., The Ohio State University Medical Center; J. Michael Boyd, Pharm.D., The Ohio State University Medical Center; Kerry Pickworth, Pharm.D., The Ohio State University Medical Center
196
Innovative clinical pharmacy services for patients undergoing percutaneous coronary interventions in a tertiary cardiology center
Julie Methot, B.Pharm., Ph.D., Quebec Heart Institute (Hôpital Laval) / Faculty of pharmacy, Université Laval; Isabelle Taillon, M.Sc., Quebec Heart Institute (Hôpital Laval) / Faculty of pharmacy, Université Laval; Marie-Josée Boily, M.Sc., Quebec Heart Institute (Hôpital Laval); Sylvain Gilbert, B.Sc., Quebec Heart Institute (Hôpital Laval) / Faculty of pharmacy, Université Laval; Karine Lejeune, M.Sc., Quebec Heart Institute (Hôpital Laval); Michelle Bernard-Genest, M.Sc., Quebec Heart Institute (Hôpital Laval); Olivier Bertrand, MD, Ph.D., Quebec Heart Institute (Hôpital Laval) / Faculty of medicine, Université Laval
197
Accuracy assessment of pharmacogenetically-predicted warfarin dosing in patients of a university hospital anticoagulation clinic
Paul B. Shaw, PharmD, UMass Memorial Medical Center; Jennifer L. Donovan, PharmD, Massachusetts College of Pharmacy and Health Sciences; Maichi T. Tran, PharmD, UMass Memorial Medical Center; Pam Burgwinkle, NP, UMass Memorial Medical Center; Joel Gore, MD, UMass Memorial Medical Center
198
Torsemide vs. furosemide plus metolazone for symptomatic chronic heart failure
Elizabeth J. Greenhalgh, Pharm.D., University of Illinois at Chicago Medical Center; Vicki L. Groo, Pharm.D., University of Illinois at Chicago Medical Center; Thomas Stamos, M.D., University of Illinois at Chicago, College of Medicine; Robert J. DiDomenico, Pharm.D., University of Illinois at Chicago
201
Utilization of transdermal lidocaine patches in rib fractures caused by thoracic blunt trauma injuries
Gina Alvis, Pharm.D., UMassMemorial Medical Center; Brian S. Smith, Pharm.D., BCPS, UMassMemorial Medical Center; Timothy Emhoff, MD FACS, UMassMemorial Medical Center; Jeffrey J. Fong, Pharm.D., BCPS, UMassMemorial Medical Center
202
Evaluation of atrial arrhythmias following non-cardiac thoracic surgery
Stephen J. Lemon Jr., PharmD, UK HealthCare - Pharmacy Services, University of Kentucky; Jeremy D. Flynn, PharmD, BCPS, UK HealthCare - Pharmacy Services, Department of Pharmacy Practice & Science, College of Pharmacy, University of Kentucky
203
Implementation of a diabetic ketoacidosis order set reduces the risk of hypoglycemia
Courtney A. Sheehan, PharmD, BCPS, Clarian Health/Methodist Hospital; Judith A Jacobi, PharmD, BCPS, FCCM, FCCP, Clarian Health/Methodist Hospital; Kari L Roemke, PharmD, BCPS, Clarian Health/Methodist Hospital
211
Characterization of a 24 hour pharmacist managed direct thrombin inhibitor (DTI) program
T. Michael Farley, PharmD, University of Kentucky HealthCare; George A. Davis, PharmD, BCPS, University of Kentucky HealthCare; Daniel A. Lewis, PharmD, BCPS, University of Kentucky HealthCare
212
Drug use evaluation of protamine and phytonadione: are the doses appropriate?
Teena Abraham, B.S., M.S., Pharm.D., BCPS, New York Methodist Hospital; Nasser Saad, B.S., Pharm.D., New York Methodist Hospital; Fabienne Vastey, B.S., Pharm.D., New York Methodist Hospital; Eric Balmir, B.S., M.S., New York Methodist Hospital; Amy Wang, Pharm.D., MBA, New York Methodist Hospital
213
Evaluation of a weight-based heparin dosing protocol in obese patients
A. Kendall Gross, PharmD, University of Kentucky HealthCare, Pharmacy Services; Tracy E. Macaulay, Pharm.D., BCPS, University of Kentucky HealthCare, Pharmacy Services; Douglas T. Steinke, Ph.D., University of Kentucky College of Pharmacy; Daniel A. Lewis, PharmD, BCPS, University of Kentucky HealthCare, Pharmacy Services
214
Risk factors associated with the conversion of methicillin-resistant Staphylococcus aureus colonization to infection in hospitalized patients
Lisa M. Harinstein, PharmD, UPMC St. Margaret; Jason J. Schafer, PharmD, UPMC St. Margaret; Frank D'Amico, PhD, UPMC St. Margaret
215
Etiology and outcomes for pneumonia patients admitted from a skilled-nursing facility (SNF): implications for empiric antibiotic therapy
Russell T. Attridge, Pharm.D., The University of Texas at Austin and The University of Texas Health Science Center at San Antonio; Christopher R. Frei, Pharm.D., M.Sc., BCPS, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio
216
Acquisition of resistance in urinary tract organisms infecting patients with spinal cord injury
Young R. Lee, Pharm.D., Texas Tech University Health Sciences Center and the Dallas Veterans Affairs Medical Center; Sara D. Brouse, Pharm.D., BCPS, Texas Tech University Health Sciences Center and the Dallas Veterans Affairs Medical Center; Susan Duquaine, Pharm.D., BCPS, VA North Texas Health Care System; Roger Bedimo, M.D., M.S., The University of Texas Southwestern Medical Center, Dallas, Texas and the Dallas Veterans Affairs Medical Center; Lance L. Goetz, M.D., The University of Texas Southwestern Medical Center, Dallas, Texas and the Dallas Veterans Affairs Medical Center
217
Aspirin prescriptions at discharge: a strategy to increase the percentage of cardiovascular patients receiving aspirin
Vanessa J. Taylor, Pharm.D., Winchester Medical Center, Shenandoah University School of Pharmacy; Marcia L. Brackbill, Pharm.D., Shenandoah University School of Pharmacy; Christine Sytsma, RN, MSN, Winchester Medical Center